Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Taisho discloses agent for cerebrovascular disorders

Nov. 8, 1996

Mitsubishi reports cathepsin B/calpain inhibitors

Nov. 8, 1996

Trophix-Children's Hospital neurodegeneration research collaboration

Nov. 8, 1996

Histamine H3 receptor ligands described by INSERM/Bioprojet

Nov. 8, 1996

Mylan generic drug approved by FDA

Nov. 8, 1996

ImmuLogic's MS therapeutic nearing the clinic

Nov. 8, 1996

FDA approval for Faulding generic anticonvulsant

Nov. 8, 1996

Nicotine analogues proposed for treatment of depression

Nov. 8, 1996

Risperidone + clozapine effective in chronic schizophrenia

Nov. 8, 1996

New treatment option for schizophrenia approved in Canada

Nov. 8, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 3, 2026.
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
EASL 2026: Emerging liver disease targets to watch
BioWorld
At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out
BioWorld
Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...